Adarx Pharmaceuticals, Inc.

ACTIVE

5871 Oberlin Dr Ste 200, 加利福尼亚州圣迭戈县, California, United Stateswww.adarx.comHolding11–50 employeesEstablished: 2019-01-01

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2019

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

44.4%

Phase 2

33.3%

Phase 3

22.2%

Trial Status Distribution

Active, not recruiting

22.2%

Recruiting

77.8%

Clinical Trials

Trials sponsored by this organization (9)

Chinese Adults With Kidney Disease

Phase 2

Recruiting

interventional

May 202630 participants

Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

Phase 3

Recruiting

interventional

Apr 202690 participants

Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Phase 1

Recruiting

interventional

Aug 202350 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations

Adarx Pharmaceuticals, Inc.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (9)

Chinese Adults With Kidney Disease

Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

Phase 1 Study of ADX-626 in Healthy Participants

Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension

Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Approvals

News